Portal hypertension in children: High-risk varices, primary prophylaxis and consequences of bleeding

被引:57
|
作者
Duche, Mathieu [1 ,2 ,3 ,4 ]
Ducot, Beatrice [5 ,6 ,7 ]
Ackermann, Oanez [1 ,2 ,3 ]
Guerin, Florent [3 ,8 ]
Jacquemin, Emmanuel [1 ,2 ,3 ,9 ]
Bernard, Olivier [1 ,2 ,3 ]
机构
[1] Hop Bicetre, AP HP, Hepatol Pediat, F-94275 Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Ctr Reference Natl Atresie Voies Biliaires, F-94275 Le Kremlin Bicetre, France
[3] Univ Paris Sud 11, F-94275 Le Kremlin Bicetre, France
[4] Hop Bicetre, AP HP, Radiol Pediat, F-94275 Le Kremlin Bicetre, France
[5] Hop Bicetre, AP HP, Sante Publ & Epidemiol, F-94275 Le Kremlin Bicetre, France
[6] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Epidemiol Reprod & Children Dev Team, F-94276 Le Kremlin Bicetre, France
[7] Univ Paris Sud 11, UMRS 1018, F-94276 Le Kremlin Bicetre, France
[8] Hop Bicetre, AP HP, Chirurg Pediat, F-94275 Le Kremlin Bicetre, France
[9] Univ Paris Sud 11, Inserm U 1174, Hepatinov, F-91405 Orsay, France
关键词
Portal hypertension; Children; Gastrointestinal bleeding; Primary prophylaxis; Biliary atresia; Cirrhosis; Endoscopy; Liver transplantation; Portal vein obstruction; ESOPHAGEAL-VARICES; BILIARY ATRESIA; LIVER-TRANSPLANTATION; GASTROESOPHAGEAL VARICES; ENDOSCOPIC LIGATION; VEIN OBSTRUCTION; SCLEROTHERAPY; HEMORRHAGE; PREDICTION; MANAGEMENT;
D O I
10.1016/j.jhep.2016.09.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Primary prophylaxis of bleeding is debated for children with portal hypertension because of the limited number of studies on its safety and efficacy, the lack of a known endoscopic pattern carrying a high-risk of bleeding for all causes, and the assumption that the mortality of a first bleed is low. We report our experience with these issues. Methods: From 1989 to 2014, we managed 1300 children with portal hypertension. Endoscopic features were recorded; high risk varices were defined as: grade 3 esophageal varices, grade 2 varices with red wale markings, or gastric varices. Two hundred forty-six children bled spontaneously and 182 underwent primary prophylaxis. The results of primary prophylaxis were reviewed as well as bleed-free survival, overall survival and life-threatening complications of bleeding. Results: High-risk varices were found in 96% of children who bled spontaneously and in 11% of children who did not bleed without primary prophylaxis (p <0.001), regardless of the cause of portal hypertension. Life-threatening complications of bleeding were recorded in 19% of children with cirrhosis and high risk varices who bled spontaneously. Ten-year probabilities of bleed-free survival after primary prophylaxis in children with high-risk varices were 96% and 72% for non-cirrhotic causes and cirrhosis respectively. Ten-year probabilities of overall survival after primary prophylaxis were 100% and 93% in children with non-cirrhotic causes and cirrhosis respectively. Conclusion: In children with portal hypertension, bleeding is linked to the high-risk endoscopic pattern reported here. Primary prophylaxis of bleeding based on this pattern is fairly effective and safe. Lay summary: In children with liver disease, the risk of bleeding from varices in the esophagus is linked to their large size, the presence of congestion on their surface and their expansion into the stomach but not to the child's age nor to the cause of portal hypertension. Prevention of the first bleed in children with high-risk varices can be achieved by surgery or endoscopic treatment, and decreases mortality and morbidity. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 50 条
  • [21] Antibiotic prophylaxis during bleeding for portal hypertension
    La Mura, V.
    Garcia Pagan, J. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1032 - 1033
  • [22] Experience With Endoscopic Management of High-Risk Gastroesophageal Varices, With and Without Bleeding, in Children With Biliary Atresia
    Duche, Mathieu
    Ducot, Beatrice
    Ackermann, Oanez
    Baujard, Catherine
    Chevret, Laurent
    Frank-Soltysiak, Marie
    Jacquemin, Emmanuel
    Bernard, Olivier
    GASTROENTEROLOGY, 2013, 145 (04) : 801 - 807
  • [23] PORTAL PRESSURE AFTER PROPHYLACTIC SCLEROTHERAPY IN PATIENTS WITH HIGH-RISK VARICES
    TOYONAGA, A
    IWAO, T
    SUMINO, M
    OHO, K
    IKEGAMI, M
    SAKAKI, M
    SHIGEMORI, H
    NAKAYAMA, M
    SASAKI, E
    TANIKAWA, K
    JOURNAL OF HEPATOLOGY, 1994, 21 (04) : 515 - 520
  • [24] Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis
    Merkel, Carlo
    Montagnese, Sara
    Amodio, Piero
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (03) : 198 - 203
  • [25] Stomal varices: a rare cause of severe bleeding in portal hypertension
    Trasancos Escura, Cristina
    Carrillo George, Carlos
    Munoz Bertran, Eduardo Domingo
    Bebia Conesa, Paloma
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (09) : 579 - 580
  • [26] MANAGEMENT OF PORTAL-HYPERTENSION AND BLEEDING ESOPHAGEAL-VARICES
    SHIELDS, R
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1977, 17 (02): : 126 - &
  • [27] Peristomal varices: another cause of bleeding in patients with portal hypertension
    Jasso-Baltazar, E.
    Ruiz-Manriquez, J.
    Zamora-Nava, L. E.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2024, 89 (01): : 165 - 166
  • [28] Stomal varices: a rare cause of severe bleeding in portal hypertension
    Nunes, Joana
    Alexandrino, Paula
    Marinho, Rui Tato
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2009, 18 (04) : 500 - 500
  • [29] Transient splenic elastography predicts high-risk esophageal varices in patients with non-cirrhotic portal hypertension
    Ferreira-Silva, Joel
    Gaspar, Rui
    Liberal, Rodrigo
    Cardoso, Helder
    Macedo, Guilherme
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (12) : 1462 - 1466
  • [30] Primary prophylaxis for portal hypertensive bleeding in cirrhosis
    Vlachogiannakos, J
    Goulis, J
    Patch, D
    Burroughs, AK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (07) : 851 - 860